Division of Radiation Oncology, The George Washington University, Washington, District of Columbia. *Corresponding Author: Yuan James Rao, Division of Radiation Oncology, The George Washington ...

This article is based on a poster originally authored by Zachary Fagiani, Rebecca L. Rich, Noah T. Ditto, Larry Yu, Michael Friedman, Glory Gao, Spencer Chiang and Jane Liu from ACROBiosystems.

研究方法 构建双特异性抗体：研究人员设计了一种四价双特异性抗体 Bi-Ab32/16，它由针对 HIV 包膜蛋白 gp120 的非中和性抗体 A32 和针对 NK 细胞表面 CD16a 受体的单链可变片段（ScFv）组成。 细胞实验：通过多种细胞实验，如细胞结合实验、细胞间接触实验、NK 细胞 ...

Currently, CAR-T cell therapy is known as an efficacious treatment for patients with relapsed/refractory hematologic malignancies. Nonetheless, this method faces several bottlenecks, including low ...

Additionally, pharmacogenomic targeting in HER2+ MBC may improve outcomes for patients carrying the CD16A-F allele for the Fc-gamma receptor due to the increased affinity of margetuximab for this ...